StockData
SELLAS Life Sciences Group, Inc. logo

SELLAS Life Sciences Group, Inc. (SLS) stock

SLSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$17.95−1.20 (-6.27%)

Close on Nov 18, 2026Market cap $3.62BP/E –Yield –

SELLAS Life Sciences price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

SELLAS Life Sciences's price to sales ratio was 29.5× on Apr 28, 2023, against 5.7× a year earlier. Over the last 2 years it ranged from 5.7× to 489.6×, with a median of 23.7×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2023Apr 28, 202329.5×−19.1
2022Dec 30, 202248.6×+39.3
2021Dec 31, 20219.2×−466.3
2015Apr 30, 2015475.6×–

More SELLAS Life Sciences figures

See a number that looks wrong?